Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Complex Diseases
Clinical phenotype and prognosis of real‐world patients with wild‐type transthyretin amyloid cardiomyopathy treated with tafamidis
Introduction Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is caused by the progressive accumulation of insoluble amyloid fibrils formed by transthyretin (TTR) in the myocardial extracellular space.1 The median survival from diagnosis of untreated patients was reported to be approximately 2–6 years.2-5 Currently, the only drug approved for the treatment of ATTR-CM in Europe is tafamidis,6 that is bound by and increases the stability of circulating transthyretin (TTR) in its...
Inflammation and genetics in myo‐pericardial diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial Diseases
Introduction Cardio-immunology is a discipline studying the interplay between the heart and immune system. This interplay is raising a lot of interest, with studies ranging from basic science to clinical research. Inflammation is a key player in several cardiovascular pathologies.
The subunit vaccine of Lumpy skin disease virus elicits significant humoral and cell-mediated immune responses in mice
1 Introduction Lumpy skin disease (LSD) is an acute, subacute, or chronic highly contagious infectious disorder afflicting cattle, caused by the Lumpy skin disease virus (LSDV). The disease is characterized by high fever, emaciation, swelling of superficial lymph nodes, lacrimation, conjunctivitis, and the appearance of prominent nodules on the skin, as well as on the mucous membranes of the oral cavity, respiratory tract, and genitalia (1).
A BtpB‐Deleted Brucella Vaccine Strain Provides Dual Advantages: Enhanced Protection and Diagnostic Differentiation Capability in Mice
1 Introduction In many countries, particularly in developing nations, the vaccination of livestock serves as the primary method for controlling the spread of brucellosis. Attenuated live vaccines are widely utilised worldwide for the prevention and management of this disease. In China, the Brucella abortus A19 vaccine strain has proven effective in curbing the transmission of brucellosis among cattle (Wang et al. 2022).
Behavioural insights in the underuse of cardiac resynchronisation therapy in heart failure: a pilot survey on incentive perceptions among referring cardiologists | Health Economics Review | Full Text
Heart failure is a leading cause of hospitalisation in patients over 50, significantly impacting both quality of life and survival. Cardiac Resynchronization Therapy (CRT) is an established treatment for patients with heart failure and concomitant electrical conduction abnormalities [1]. CRT is typically indicated for patients with reduced left ventricular ejection fraction (< 35%), left bundle branch block, and symptomatic heart failure despite optimal medical therapy [2, 3].
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non‐dilated cardiomyopathy
Introduction Left ventricular reverse remodelling (LVRR) is classically defined as the ability of the left ventricle to improve its systolic function, associated with dimensions and shape improvement when dilatation is present.1-4 LVRR has been described in a consistent share of dilated cardiomyopathy (DCM) and non-dilated left ventricular cardiomyopathy (NDLVC) patients presenting with left ventricular (LV) systolic dysfunction and treated with tailored therapies for heart failure with...
An update on the ESC Council on Cardiovascular Genomics: out from the niche into the open
Medicine—in particular, the field of cardiology—has undergone remarkable transformations over the past few decades by achieving milestones in disease understanding, technology, and medical therapy. In this wealth of achievements, genetics and genomic medicine play a rapidly growing role and have now entered the clinical scene. While the potential of genomic medicine to improve patient outcomes is huge, its implementation in routine cardiovascular care remains challenging.
Critical analysis of the 2023 ESC guidelines on cardiomyopathy management
One year after their publication, the first European Society of Cardiology (ESC) guidelines on the management of cardiomyopathies (CMPs)1 are still extremely timely and relevant.
Landiolol is effective and safe in paediatric supraventricular tachycardia: Evidence from a European prospective multicentre open-label Phase III study (LANDI-PED)
Landiolol, an ultra-fast acting super-selective beta-blocker, was investigated for the first time in Europe in a prospective clinical study for the management of supraventricular tachycardia (SVT) among paediatric patients. LANDI-PED was a prospective, multicentre, open-label, uncontrolled phase III study aiming to investigate the efficacy, safety, and pharmacokinetics (PK) of landiolol in paediatric patients.
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration
Key Points Question What is the clinical phenotype and natural history of patients with asymptomatic transthyretin (ATTR) cardiac amyloid infiltration? Findings In this cohort study of 485 patients with asymptomatic ATTR cardiac amyloid infiltration, those with grade 2 or 3 cardiac uptake had greater rates of disease progression and a 5-fold higher risk of cardiovascular death compared with those with grade 1 uptake, in whom noncardiovascular death was predominant.
The emerging role of clonal haematopoiesis in the pathogenesis of dilated cardiomyopathy
Dilated cardiomyopathy (DCM) is defined by the presence of left ventricular dilatation and systolic dysfunction unexplained solely by abnormal loading conditions or coronary artery disease.1 The causes of DCM are heterogeneous, including both genetic and environmental factors, also determining the disease progression and outcome.2,3 Chronic myocardial inflammation is often present in patients with DCM, and can be either the cause or consequence of disease progression.4 A broad and aggressive...
Lung damage in SARS‐CoV‐2 patients: An autopsy study in the era of vaccination
1 INTRODUCTION A century after the 1918–1920 influenza pandemic, the coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)1, 2 has demonstrated the major impact of a viral illness on healthcare systems over a narrow time period. Understanding of SARS-CoV-2 infection has evolved since early 2020.
Aficamten in non‐obstructive hypertrophic cardiomyopathy: Unlocking new horizons?
Corresponding Author Gianfranco Sinagra Cardiothoracovascular Department, Center for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste, Trieste, Italy European Reference Network for Rare, Low-Prevalence, and Complex Diseases of the Heart (ERN GUARD-Heart) Corresponding author. Cardiothoracovascular Department, University of Trieste, Via Valdoni 7, 34129 Trieste, Italy.
Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis
Key Points Question What is the role of cardiovascular magnetic resonance (CMR) with extracellular volume (ECV) mapping in systemic light-chain (AL) amyloidosis? Findings This cohort study involved 560 patients newly diagnosed with systemic AL amyloidosis undergoing CMR with ECV mapping before chemotherapy.
Genotype is associated with left ventricular reverse remodelling and early events in recent‐onset dilated cardiomyopathy
Introduction The heterogeneous aetiology of dilated cardiomyopathy (DCM), which consists of genetic, inflammatory, toxic, and metabolic causes, complicates accurate diagnostic and prognostic classification of the disease.1 This is most evident in individuals with recent-onset dilated cardiomyopathy (RODCM), who develop a broad spectrum of outcomes ranging from end-stage heart failure or sudden cardiac death to a more favourable outcome of left ventricular reverse remodelling (LVRR).2, 3 LVRR...
A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome
Key Points Question Cardiac arrest frequently occurs without explanation, even after a thorough clinical evaluation. Can a simple maneuver clinically diagnose calcium release deficiency syndrome (CRDS), a newly described cause of sudden death? Findings In this international, multicenter, case-control study, a provoked measure of T-wave amplitude on an electrocardiogram ascertained cases of CRDS with high accuracy.
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
The year 2023 is the first year since 2011 in which three hot line presentations of clinical trials in patients with atrial fibrillation (AF) were presented at the annual congress of the European Society of Cardiology (ESC) and simultaneously published in the New England Journal of Medicine (CASTLE-HTx, ADVENT, and NOAH-AFNET 6).1–3 In November 2023, ARTESiA was presented and published.4 Unlike in 2011, when the focus was on anticoagulation,5–7 two of the trials presented at ESC evaluated AF...
Apoptosis, a useful marker in the management of hot‐phase cardiomyopathy?
Corresponding Author Marco Merlo Cardiovascular Department, Center for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste, Trieste, Italy European Reference Network for Rare, Low-Prevalence, and Complex Diseases of the Heart (ERN GUARD-Heart) Contributed equally as first authors. Corresponding author.
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy characterized by progressive fibro-fatty replacement of the myocardium which predisposes patients to ventricular arrhythmias (VAs) and sudden cardiac death (SCD).1 Prevention of SCD through the placement of an implantable cardioverter-defibrillator (ICD) thus represents a mainstay of ARVC management.
Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population
Corresponding Author Marco Canepa Cardiovascular Unit, Department of Internal Medicine, University of Genova, Italy Cardiovascular Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy Corresponding author.
Dilated cardiomyopathy: second hits knock-down the heart
Dilated cardiomyopathy (DCM) is commonly defined as the presence of left ventricular (LV) or biventricular dilatation and global or regional systolic dysfunction unexplained solely by abnormal loading conditions (e.g. hypertension or primary valve disease) or significant coronary artery disease sufficient to cause ventricular remodelling.1 The prevalence is estimated to ∼1 in 250 people, and annual incidence of DCM at 5–8 per 100 000 patients.
Coronary artery disease and dilated cardiomyopathy: where parallel universes merge
Corresponding Author Marco Merlo Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Italy. Member of the European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart) Corresponding author. Marco Merlo, MD, Cardiovascular Department, Azienda Sanitaria Universitaria Integrata di Trieste and University of Trieste, Via P.
Athletes and suspected catecholaminergic polymorphic ventricular tachycardia: Awareness and current knowledge
Josep Brugada MD, PhD Arrhythmia, Inherited Cardiac Diseases and Sudden Death Unit, Hospital Sant Joan de Deu, Universitat de Barcelona, Barcelona, Spain Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain Member of the European Reference Network for Rare, Low Prevalence and...
Editorial: Proceedings and predictions in cardiac amyloidosis: unsolved mysteries and challenges for the future
“Sic parvis magna” – Sir Francis Drake Perceptions of amyloidosis have changed dramatically over the recent years following major advances in diagnosis and therapeutic strategies (1), especially in the field of cardiac amyloidosis (2). Recognition of disease and confirmation of final diagnosis, clinical management and treatment approaches represent ongoing challenges (3).
Final farewell to Claudio Rapezzi: observation, deduction and knowledge in medicine
Many colleagues have known him as a brilliant mind and prominent member of the cardiological and amyloidosis community, many others as a trustful and distinguished partner in research with flashes of extraordinary intelligence and an exceptional ability for lateral thinking, and many more as a close friend with extremely sharp irony and culture.
Electrocardiogram analysis in Anderson-Fabry disease A valuable tool for progressive phenotypic expression tracking
Electrocardiogram analysis in Anderson-Fabry disease A valuable tool for progressive phenotypic expression tracking Vanda Parisi1, 2 , Riccardo Baldassarre1, 2 , Valentina Ferrara3, Raffaello Ditaranto1, 2 , Fausto Barlocco4, Rosa Lillo5, Federica Re6, Giacomo Marchi7 , Chiara Chiti8 , Federico Di Nicola1, 2, Costantina Catalano1, 2, Ludovica Barile1, 2, Maria A. Schiavo1, 2, Alberto Ponziani1, 2, Giulia Saturi1, 2 , Angelo G.
Screening approaches to cardiac amyloidosis in different clinical settings: current practice and future perspectives
Angelo Giuseppe Caponetti1, 2, Antonella Accietto1, 2, Giulia Saturi1, 2, Alberto Ponziani1, 2, Maurizio Sguazzotti1, 2, Paolo Massa1, 2, Alessandro Giovannetti1, 2, Raffaello Ditaranto1, 2, Vanda Parisi1, 2, Ornella Leone3, Pietro Guaraldi4, Pietro Cortelli4, Christian Gagliardi1, 5, Simone Longhi1, 5, Nazzareno Galie1, 2 and Elena Biagini1, 5* 1Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy, Italy 2Department of...
Diagnosis and management of rare cardiomyopathies in adult and paediatric patients
Highlights • Rare cardiomyopathies (CMPs) require tailored investigation and management. • A multidisciplinary team is essential to improve diagnosis and management of rare CMPs. • A step-by-step clinical evaluation is required to reach aetiological diagnosis.
Abstract Inhibition of the master growth regulator mTORC1 (mechanistic target of rapamycin complex 1) slows ageing across phyla, in part by reducing protein synthesis. Various stresses globally suppress protein synthesis through the integrated stress response (ISR), resulting in preferential translation of the transcription factor ATF-4. Here we show in C.
Single-cell RNA Sequencing Reveals How the Aryl Hydrocarbon Receptor Shapes Cellular Differentiation Potency in the Mouse Colon
Skip Nav Destination Research Articles| January 06 2022
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Abstract Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the hereditary forms or as a consequence of acquired conditions. Thanks to advances in imaging techniques and the possibility of achieving a non-invasive diagnosis, we now know that cardiac amyloidosis is a more frequent disease than traditionally considered.
Membrane therapy using DHA suppresses epidermal growth factor receptor signaling by disrupting nanocluster formation
Abstract Epidermal growth factor receptor (EGFR) signaling drives the formation of many types of cancer, including colon cancer. Docosahexaenoic acid (DHA, 22∶6Δ4,7,10,13,16,19), a chemoprotective long-chain n-3 polyunsaturated fatty acid suppresses EGFR signaling. However, the mechanism underlying this phenotype remains unclear.
The hospitalizations in hypertrophic cardiomyopathy: “the dark side of the moon”.
Hypertrophic cardiomyopathy (HCM) is a myocardial disease characterized by left ventricular hypertrophy not solely explainable by abnormal loading condition [ 1 Authors/Task Force members, Elliott PM Anastasakis A. Borger M.A. Borggrefe M. Cecchi F. Charron P. Hagege A.A. Lafont A. Limongelli G. Mahrholdt H. WJ McKenna Mogensen J. Nihoyannopoulos P. Nistri S. Pieper P.G. Pieske B. Rapezzi C. Rutten F.H. Tillmanns C. Watkins H.
p53 Protects Cells from Death at the Heatstroke Threshold Temperature
Highlights • p53 promotes survival by preventing a hyperreactive heat shock response (HSR) at 40°C • Excessive HSC70-mediated protein degradation (hyperreactive HSR) causes death at 40°C • HSP90 stabilizes p53 without phosphorylation at S37 to repress HSR at 40°C • ATM phosphorylates p53 at S37 to induce apoptosis in hyperthermia conditions Summary When the core body temperature is higher than 40°C, life is threatened due to heatstroke.
AdipoRon attenuates Wnt signaling by reducing cholesterol-dependent plasma membrane rigidity
Abstract The increasing prevalence of adult and adolescent obesity and its associated risk of colorectal cancer reinforces the urgent need to elucidate the underlying mechanisms contributing to the promotion of colon cancer in obese individuals. Adiponectin is an adipose tissue-derived adipokine, whose levels are reduced during obesity. Both epidemiological and preclinical data indicate that adiponectin suppresses colon tumorigenesis.
Reply
Article in Press Reply , Xiaofeng Jiang x Xiaofeng Jiang Search for articles by this author Affiliations Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Mass Department of Genetics, and Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, Mass , PhD b,c , Quan Lu x Quan Lu Search for articles by this author Affiliations Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Mass Department of Genetics, and...
Setting fire to fat
Zhihui Zhang‡ and Min-Dian Li§1 From the ‡Department of Cardiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China 400038 and the §Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts 02115 ↵1 To whom correspondence should be addressed: Dept. of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, 677 Huntington Ave., Boston, MA 02115.
Setting fire to fat
Zhihui Zhang‡ and Min-Dian Li§1 From the ‡Department of Cardiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China 400038 and the §Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts 02115 ↵1 To whom correspondence should be addressed: Dept. of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, 677 Huntington Ave., Boston, MA 02115.
Neuronal TORC1 modulates longevity via AMPK and cell nonautonomous regulation of mitochondrial dynamics in C. elegans
New Results Yue Zhang, Anne Lanjuin, Suvagata Roy Chowdhury, Meeta Mistry, Carlos G. Silva Garcia, Heather J. Weir, Chia-Lin Lee, Caroline C. Escoubas, Emina Tabakovic, View ORCID ProfileWilliam B. Mair doi: https://doi.org/10.1101/665190 Abstract Target of rapamycin complex 1 (TORC1) and AMP-activated protein kinase (AMPK) antagonistically modulate metabolism and aging. However, how they coordinate to determine longevity and if they act via separable mechanisms is unclear.
Loss of bronchoprotection with ICS plus LABA treatment, β-receptor dynamics, and the effect of alendronate
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Fig 1 ALfA trial study schema: ex vivo B2AR assays were conducted on PBMCs. These included radioligand binding assays to quantify B2AR cell-surface density and cAMP ELISAs to measure B2AR intracellular signaling.
Direct stimulation of NADP+ synthesis through Akt-mediated phosphorylation of NAD kinase
Download and print this article for your personal scholarly, research, and educational use. Buy a single issue of Science for just $15 USD.
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids
Highlights • Treatment of cells with palmitate increases saturated glycerolipids and ER stress • Di-saturated glycerolipids are key to lipotoxicity in this model • Inhibiting ER-localized GPAT enzymes protects cells from lipotoxicity • Depletion of the putative E3 ligase RNF213 protects cells from lipotoxicity Summary Excessive levels of saturated fatty acids are toxic to cells, although the basis for this lipotoxicity remains incompletely understood.
Molecular logic of mTORC1 signalling as a metabolic rheostat
Abstract The protein kinase complex mechanistic target of rapamycin complex 1 (mTORC1) serves as a key conduit between growth signals and the metabolic processes underlying cell growth. The activation state of mTORC1 is controlled by intracellular nutrients and energy, as well as exogenous hormones and growth factors, thereby integrating local and systemic growth signals.
Metabolism as a guiding force for immunity
Abstract Recent studies indicate that cellular metabolism plays a key role in supporting immune cell maintenance and development. Here, we review how metabolism guides immune cell activation and differentiation to distinct cellular states, and how differential regulation of metabolism allows for context-dependent support during activation and lineage commitment.
Lysosomal catch-and-release controls mTORC1
Rag GTPases facilitate mTORC1 activation by recruiting it to Rheb at the lysosome when amino acids are abundant. A study now shows that the amino acid-induced change in the GTP/GDP-binding state of the Rag heterodimer paradoxically increases its dynamic release from the Ragulator at the lysosome and may limit mTORC1 activation.
TACI-Deficient Macrophages Protect Mice Against Metaflammation and Obesity-Induced Dysregulation of Glucose Homeostasis
TACI-Deficient Macrophages Protect Mice Against Metaflammation and Obesity-Induced Dysregulation of Glucose Homeostasis Lunhua Liu, Karen Etsuko Inouye, Windy Rose Allman, Adam Steven Coleman, Shafiuddin Siddiqui, Gökhan Siddik Hotamisligil, Mustafa Akkoyunlu Diabetes Aug 2018, 67 (8) 1589-1603; DOI: 10.2337/db17-1089
Long chain n-3 fatty acids attenuate oncogenic KRas-driven proliferation by altering plasma membrane nanoscale proteolipid composition
AbstractRas signaling originates from transient nanoscale compartmentalized regions of the plasma membrane composed of specific proteins and lipids. The highly specific lipid composition of these nanodomains, termed nanoclusters, facilitates effector recruitment and therefore influences signal transduction. This suggests that Ras nanocluster proteolipid composition could represent a novel target for future chemoprevention interventions.
Emerging Role of mTOR in the Response to Cancer Therapeutics
The movement toward precision medicine for cancer therapy has been hindered by innate and acquired resistance to targeted therapeutics. Common oncogenes and tumor suppressors act in a signaling network that converges on mTORC1, leading to its aberrant activation in the majority of tumors. While mTOR inhibitors are effective as monotherapies in some tumor settings, such as tuberous sclerosis complex, they are generally not sufficient to achieve antitumor responses in most sporadic cancers.
Amino Acid Restriction Triggers Angiogenesis via GCN2/ATF4 Regulation of VEGF and H2S Production
Angiogenesis, the formation of new blood vessels by endothelial cells (ECs), is an adaptive response to oxygen/nutrient deprivation orchestrated by vascular endothelial growth factor (VEGF) upon ischemia or exercise. Hypoxia is the best-understood trigger of VEGF expression via the transcription factor HIF1α. Nutrient deprivation is inseparable from hypoxia during ischemia, yet its role in angiogenesis is poorly characterized.
A functional splicing variant associated with decreased asthma risk abolishes the ability of gasdermin B (GSMDB) to induce epithelial cell pyroptosis
Publication HistoryPublished online: January 09, 2018Accepted: November 22, 2017; Received in revised form: November 12, 2017; Received: May 20, 2017;
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Complex
Contact Complex, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack